Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri
Valproic acid (VPA) is the most commonly used antiepileptic drug (AED) in Malaysia. However, studies on pharmacokinetic profiles of VPA in obese epileptic population are limited. Thus, a retrospective analysis study was conducted to evaluate the pharmacokinetic profiles’ differences between obese an...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://ir.uitm.edu.my/id/eprint/26247/1/TM_NURUL%20HUSNA%20SODRI%20PH%2017_5.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
my-uitm-ir.26247 |
|---|---|
| record_format |
uketd_dc |
| spelling |
my-uitm-ir.262472022-04-13T03:53:37Z Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri 2017 Sodri, Nurul Husna Drugs and their actions Valproic acid (VPA) is the most commonly used antiepileptic drug (AED) in Malaysia. However, studies on pharmacokinetic profiles of VPA in obese epileptic population are limited. Thus, a retrospective analysis study was conducted to evaluate the pharmacokinetic profiles’ differences between obese and non-obese adult patients taking VPA monotherapy. The study also evaluated the relationship between the total body weight (TBW) and ideal body weight (IBW) and the VPA clearance (CL). A total of 224 samples from the routinely collected data in Hospital Tengku Ampuan Rahimah Klang a tertiary hospital were analysed, with 109 samples grouped as obese patients and 115 as non-obese. A regression analysis was also performed in order to characterize the patient’s factors which influence VPA CL .The pharmacokinetic profiles of VPA were statistically significant difference between the two groups (p < 0.05). TBW and IBW were found to have the similar strength of relationship in determining the VPA CL and dosing regimen. The regression model for VPA CL in study population included TBW (kg) and daily dose (mg/kg/day) as factors that have significant influence. The final model was as follows: CL (L/hr) = (0.005*TBW) + (0.018*daily dose) – 0.001. In conclusion, this study demonstrated significant differences in VPA pharmacokinetic profiles between obese and non-obese patients. TBW or IBW can be used in determining the dosing regimen and the estimation of VPA CL in obese patients 2017 Thesis https://ir.uitm.edu.my/id/eprint/26247/ https://ir.uitm.edu.my/id/eprint/26247/1/TM_NURUL%20HUSNA%20SODRI%20PH%2017_5.pdf text en public masters Universiti Teknologi MARA Faculty of Pharmacy |
| institution |
Universiti Teknologi MARA |
| collection |
UiTM Institutional Repository |
| language |
English |
| topic |
Drugs and their actions |
| spellingShingle |
Drugs and their actions Sodri, Nurul Husna Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| description |
Valproic acid (VPA) is the most commonly used antiepileptic drug (AED) in Malaysia. However, studies on pharmacokinetic profiles of VPA in obese epileptic population are limited. Thus, a retrospective analysis study was conducted to evaluate the pharmacokinetic profiles’ differences between obese and non-obese adult patients taking VPA monotherapy. The study also evaluated the relationship between the total body weight (TBW) and ideal body weight (IBW) and the VPA clearance (CL). A total of 224 samples from the routinely collected data in Hospital Tengku Ampuan Rahimah Klang a tertiary hospital were analysed, with 109 samples grouped as obese patients and 115 as non-obese. A regression analysis was also performed in order to characterize the patient’s factors which influence VPA CL .The pharmacokinetic profiles of VPA were statistically significant difference between the two groups (p < 0.05). TBW and IBW were found to have the similar strength of relationship in determining the VPA CL and dosing regimen. The regression model for VPA CL in study population included TBW (kg) and daily dose (mg/kg/day) as factors that have significant influence. The final model was as follows: CL (L/hr) = (0.005*TBW) + (0.018*daily dose) – 0.001. In conclusion, this study demonstrated significant differences in VPA pharmacokinetic profiles between obese and non-obese patients. TBW or IBW can be used in determining the dosing regimen and the estimation of VPA CL in obese patients |
| format |
Thesis |
| qualification_level |
Master's degree |
| author |
Sodri, Nurul Husna |
| author_facet |
Sodri, Nurul Husna |
| author_sort |
Sodri, Nurul Husna |
| title |
Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| title_short |
Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| title_full |
Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| title_fullStr |
Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| title_full_unstemmed |
Pharmacokinetic profiles among obese and non-obese patients on valproate acid in Hospital Tengku Ampuan Rahimah: a retrospective evaluation / Nurul Husna Sodri |
| title_sort |
pharmacokinetic profiles among obese and non-obese patients on valproate acid in hospital tengku ampuan rahimah: a retrospective evaluation / nurul husna sodri |
| granting_institution |
Universiti Teknologi MARA |
| granting_department |
Faculty of Pharmacy |
| publishDate |
2017 |
| url |
https://ir.uitm.edu.my/id/eprint/26247/1/TM_NURUL%20HUSNA%20SODRI%20PH%2017_5.pdf |
| _version_ |
1783733887628738560 |